- Recruiting
A Long-term, Post-marketing Safety Study of Palynziq in Patients With PKU (PALace)
This study looks at the long-term safety of a medicine called pegvaliase for people with Phenylketonuria (PKU). It helps us understand side effects and how well safety precautions work over 10 years.
For: Phenylketonuria (PKU)United States · Germany · Italy - Recruiting
A Global, Multicenter Study to Assess Maternal, Fetal and Infant Outcomes of Exposure to Palynziq® (Pegvaliase) During Pregnancy and Breastfeeding
This study looks at how a medicine called Palynziq (pegvaliase) affects pregnant women with a condition called PKU, and their babies, both during pregnancy and while breastfeeding. It aims to understand the safety and outcomes for mothers and infants.
For: Phenylketonuria, MaternalUnited States · Canada · Germany - Active not recruitingPHASE3
Study to Evaluate the Safety and Efficacy of Pegvaliase in Adolescents (Ages 12-17) With Phenylketonuria
This study looks at a new injection called pegvaliase for teenagers aged 12-17 with PKU whose current treatment isn't quite managing their condition. It aims to see if pegvaliase is safe and works better than just diet for controlling PKU.
For: Phenylketonuria (PKU)United States · Germany